New SEC Form D filing
Pace Pharmaceuticals, Inc., 2026-09-28
A new SEC Form D private-offering notice from Cupertino, CA, an undisclosed offering target in Biotech. The source filing is one click away.
What this filing says
Pace Pharmaceuticals, Inc. Verified via SEC Form D
Filed 4 days agoFiled to raise Undisclosed The filer declared an indefinite offering amount; we say so instead of inventing a number.First money in 2026-09-18Raised so far $50,000HQ (as filed) Cupertino, CASector Biotech machine-classified from the filing aloneStage (inferred) Pre-seedCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 1 executive & director
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- BlueOne Technologies, Inc., 2026-09-29, $7M, Newport Beach, CA
- GT Biopharma, Inc., 2026-09-29, $39M, San Francisco, CA
- Xact Bio, Inc., 2026-09-28, $18M, Boston, MA
- Circlz Labs, Inc., 2026-09-28, $100K, San Francisco, CA
- Laurentide Therapeutics Inc., 2026-09-28, $100K, Atlanta, GA
- SoberSphere Inc, 2026-09-28, $500K, Palm Desert, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.